Jelmer Visser tracks for Innovation Origins the movements of the coronary pandemic in Europe. This week: which countries score best (and worst) in vaccinating their population?
The vaccine from Pfizer and BioNTech is 90 percent effective. Today, the companies announced the preliminary results of their phase three trials.
The Belgian company Janssen is starting the final phase of their vaccine research in the United States, South Africa and South America. The Netherlands will also have its turn soon.